Grünenthal GmbH: all 92 studies

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• A Clinical Trial of GRT7040 in Adults With Acute Pain Following BunionectomyNot yet recruitingNCT07807644Phase 2
• A First-in-human Trial of GRT7041 in Healthy ParticipantsRecruitingNCT07289776Phase 1
• Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the KneeCompletedNCT05449132Phase 3Results posted
• Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the KneeCompletedNCT05377489Phase 3Results posted
• Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee OsteoarthritisCompletedNCT05248386Phase 3Results posted
• Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After SurgeryCompletedNCT04967664Phase 3Results posted
• Tramadol/Diclofenac Fixed-dose Combination Phase III Trial in Acute Pain After Third Molar ExtractionCompletedNCT03714672Phase 3Results posted
• A Clinical Study to Compare MAR-CUTIS With Dermabond AdvancedTerminatedNCT03688880Not applicableResults posted
• Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)TerminatedNCT03560986Phase 3Results posted
• Efficacy and Safety of Intravenous Neridronic Acid in CRPSTerminatedNCT03530345Phase 3Results posted
• Safety of Intravenous Neridronic Acid in CRPSCompletedNCT02972359Phase 3Results posted
• Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm DeliveryCompletedNCT02225353Phase 2Results posted
• Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years OldTerminatedNCT02221674Phase 2Results posted
• A Study to Look at Tapentadol Tablets in Children and Adolescents in PainCompletedNCT02151682Phase 2/3Results posted
• A Study to Look at Tapentadol Oral Solution in Children and Adolescents in PainCompletedNCT02081391Phase 3Results posted
• Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.CompletedNCT01838616Phase 4Results posted
• Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative PainCompletedNCT01729728Phase 2Results posted
• A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic PainTerminatedNCT01485094Phase 2Results posted
• Intravenous Tapentadol in Post-Bunionectomy PainCompletedNCT01435577Phase 2Results posted
• Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and PregabalinCompletedNCT01352741Phase 4Results posted
• Tapentadol in Chronic Malignant Tumour Related PainTerminatedNCT01264887Phase 3Results posted
• A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983YTerminatedNCT01056315Phase 2Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of TolerabilityTerminatedNCT00986258Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular AnalgesicsCompletedNCT00983385Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular AnalgesicCompletedNCT00983073Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.TerminatedNCT00982280Phase 3Results posted
• A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After BunionectomyCompletedNCT00609466Phase 3Results posted
• A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and MorphineTerminatedNCT00505414Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the KneeCompletedNCT00486811Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal HysterectomyCompletedNCT00478023Phase 3Results posted
• A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and MorphineCompletedNCT00472303Phase 3Results posted
• Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019CompletedNCT07479745Phase 1
• A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male ParticipantsCompletedNCT07347548Phase 1
• A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male ParticipantsCompletedNCT07317063Phase 1
• Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral NeuropathyActive, not recruitingNCT06495424
• Bioavailability of Eszopiclone 3.0 mg With Regards to Reference ProductCompletedNCT05349396Phase 1
• Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference ProductCompletedNCT05332106Phase 1
• Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference ProductCompletedNCT05282940Phase 1
• Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference ProductCompletedNCT05250141Phase 1
• Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference ProductCompletedNCT05158192Phase 1
• Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference ProductCompletedNCT05083325Phase 1
• Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Feeding ConditionsCompletedNCT04751318Phase 1
• Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting ConditionsCompletedNCT04723238Phase 1
• Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference ProductCompletedNCT04713904Phase 1
• Bioavailability of Clotiazepam 5 mg With Regards to Reference ProductCompletedNCT04440423Phase 1
• Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference ProductCompletedNCT04422028Phase 1
• Bioavailability of Dienogest 2.0 mg With Regards to Reference ProductCompletedNCT04230083Phase 1
• Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference ProductCompletedNCT04230070Phase 1
• Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference ProductCompletedNCT04194905Phase 1
• Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference ProductCompletedNCT04193852Phase 1
• Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract InfectionsCompletedNCT04016051Phase 3
• Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)CompletedNCT03979989Phase 1
• Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)CompletedNCT03967964Phase 1
• Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy VolunteersCompletedNCT03956134Phase 1
• Investigation How CG5503 is Taken up and Excreted From the Body After 2 Minutes Intravenous Infusion With and Without Oral Co-administration of CharcoalCompletedNCT03951987Phase 1
• Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and WomenCompletedNCT03951402Phase 1
• A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting ConditionsWithdrawnNCT03905564Phase 1
• Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference PatchCompletedNCT03785613Phase 1
• Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With FibromyalgiaCompletedNCT03783910Phase 2
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy SubjectsCompletedNCT03776110Phase 1
• Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 HoursCompletedNCT03770234Phase 1
• A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure Which Aims to Evaluate Whether GRT0151Y is Likely to be AbusedCompletedNCT03768024Phase 1
• Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic InteractionCompletedNCT03767036Phase 1
• Pharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and DiclofenacCompletedNCT03766984Phase 1
• A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the Effect of Food on itCompletedNCT03765801Phase 1
• A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic NeuralgiaCompletedNCT03765697Phase 3
• A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally ToleratedCompletedNCT03765658Phase 1
• A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for PleasureCompletedNCT03765346Phase 1
• A Clinical Study in Healthy Subjects Which Aims to Investigate the Safety, the Tolerability and the Effects of GRT0151Y and How the Compound is Taken up and Excreted From the BodyCompletedNCT03761407Phase 1
• Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol AcetateWithdrawnNCT03749733Phase 1
• A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)CompletedNCT03745404Phase 3
• Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal WomenCompletedNCT03737656Phase 1
• A Study in Healthy Male Volunteers to Investigate the Safety and Tolerability of a Single Dose of Neosaxitoxin Alone and in Combination With Bupivacaine (With and Without Epinephrine) for Brachial Plexus BlockadeTerminatedNCT03399435Phase 1
• A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy AdultsWithdrawnNCT03137030Phase 1
• A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy AdultsWithdrawnNCT03137017Phase 1
• Naloxegol US PMR CV Safety.Active, not recruitingNCT02813356
• Intra-articular Lopain (MTX-071) Phase I/IIa Study in Chronic Osteoarthritic Knee Joint PainCompletedNCT02566564Phase 1
• Efficacy and Safety of Intravenous Neridronic Acid in CRPS-ICompletedNCT02402530Phase 2/3
• Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian ReserveCompletedNCT02268032Phase 1
• Assessment of a Vaginal Ring With Meloxicam in the Treatment of DysmenorrheaCompletedNCT02255045Phase 2/3
• Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile WomenCompletedNCT01839643Phase 1
• Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve PainCompletedNCT01752322Phase 3
• Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal WomenCompletedNCT01721993Phase 1
• Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric AsthmaCompletedNCT01333800Phase 4
• Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative PainTerminatedNCT01155986Phase 2
• Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back PainCompletedNCT01043263Phase 2
• Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)TerminatedNCT00469404Phase 1
• Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)TerminatedNCT00469053Phase 1
• Bioequivalence Trial of a New Opioid Combination Compared to ReferenceCompletedNCT00460785Phase 1
• Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic PainCompletedNCT00414349Phase 3
• Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch FormulationsTerminatedNCT00388219Phase 1
• Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch FormulationsTerminatedNCT00387777Phase 1

← Grünenthal GmbH overview and focus areas